Culture

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

image: Venugopal Gudipati, Johannes B. Huppa, Judith H. Aberle, Maximilian Koblischke Andreas Bergthaler, Benedikt Agerer.

Image: 
© Laura Alvarez / CeMM

The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them. Scientists from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have now shown that SARS-CoV-2 can make itself unrecognizable to the immune response by T-killer cells through mutations. The findings of the research groups of Andreas Bergthaler, Judith Aberle and Johannes Huppa provide important clues for the further development of vaccines and were published in the journal Science Immunology.

After a year of the pandemic, an increasingly clear picture is emerging for science and medicine of how the immune response protects people from SARS-CoV-2. Two protagonists play central roles: antibodies and T-killer cells (also called cytotoxic CD8 T cells). While antibodies dock directly onto viruses to render them harmless, T-killer cells recognize viral protein fragments on infected cells and subsequently kill them to stop virus production. More and more studies show that SARS-CoV-2 can evade the antibody immune response through mutations and thus also impair the effectiveness of vaccines. Whether such mutations also affect T-killer cells in their function had not been clarified so far. Benedikt Agerer in the laboratory of Andreas Bergthaler (CeMM), Maximilian Koblischke and Venugopal Gudipati in the research groups of Judith Aberle and Johannes Huppa (both Medical University of Vienna) have now worked together closely to investigate the effect of viral mutations in so-called T cell epitopes, i.e., in regions recognized by T-killer cells. For this purpose, they sequenced 750 SARS-CoV-2 viral genomes from infected individuals and analyzed mutations for their potential to alter T cell epitopes. "Our results show that many mutations in SARS-CoV-2 are indeed capable of doing this. With the help of bioinformatic and biochemical investigations as well as laboratory experiments with blood cells from COVID-19 patients, we were able to show that mutated viruses can no longer be recognized by T-killer cells in these regions," says Andreas Bergthaler.

Focus on spike protein might be too narrow

In most natural infections, several epitopes are available for recognition by T-killer cells. If the virus mutates in one place, it is likely that other epitopes indicate the presence of the virus.

Most of the current vaccines against SARS-CoV-2 are directed exclusively against the so-called spike protein, which is one of 26 virus proteins. This also reduces the number of epitopes that are available for recognition by T-killer cells. "The spike protein has, on average, one to six of these T cell epitopes in an infected person. If the virus mutates in one of these regions, the risk that the infected cells will not be recognized by the T-killer cells increases," explains Johannes Huppa. Judith Aberle emphasizes: "Especially for the further development of vaccines, we therefore have to keep a close eye on how the virus mutates and which mutations prevail globally. Currently, we see few indications that mutations in T killer cell epitopes are increasingly spreading."

The study authors see no reason in their data to believe that SARS-CoV-2 can completely evade the human immune response. However, these results provide important insights into how SARS-CoV-2 interacts with the immune system. "Furthermore, this knowledge helps to develop more effective vaccines with the potential to activate as many T-killer cells as possible via a variety of epitopes. The goal are vaccines that trigger neutralizing antibody and T killer cell responses for the broadest possible protection," the study authors say.

Credit: 
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences

Volcanoes might light up the night sky of this planet

image: This artist's illustration represents the possible interior dynamics of the super-Earth exoplanet LHS 3844b. The planet's interior properties and the strong stellar irradiation might lead to a hemispheric tectonic regime.

Image: 
© Universität Bern / University of Bern, Illustration: Thibaut Roger

On Earth, plate tectonics is not only responsible for the rise of mountains and earthquakes. It is also an essential part of the cycle that brings material from the planet's interior to the surface and the atmosphere, and then transports it back beneath the Earth's crust. Tectonics thus has a vital influence on the conditions that ultimately make Earth habitable.

Until now, researchers have found no evidence of global tectonic activity on planets outside our solar system. A team of researchers led by Tobias Meier from the Center for Space and Habitability (CSH) at the University of Bern and with the participation of ETH Zurich, the University of Oxford and the National Center of Competence in Research NCCR PlanetS has now found evidence of the flow patterns inside a planet, located 45 light-years from Earth: LHS 3844b. Their results were published in The Astrophysical Journal Letters.

An extreme contrast and no atmosphere

"Observing signs of tectonic activity is very difficult, because they are usually hidden beneath an atmosphere", Meier explains. However, recent results suggested that LHS 3844b probably does not have an atmosphere. Slightly larger than Earth and likely similarly rocky, it orbits around its star so closely that one side of the planet is in constant daylight and the other in permanent night - just like the same side of the Moon always faces the Earth. With no atmosphere shielding it from the intense radiation, the surface gets blisteringly hot: it can reach up to 800°C on the dayside. The night side, on the other hand, is freezing. Temperatures there might fall below minus 250°C. "We thought that this severe temperature contrast might affect material flow in the planet's interior", Meier recalls.

To test their theory, the team ran computer simulations with different strengths of material and internal heating sources, such as heat from the planet's core and the decay of radioactive elements. The simulations included the large temperature contrast on the surface imposed by the host star.

Flow inside the planet from one hemisphere to the other

"Most simulations showed that there was only upwards flow on one side of the planet and downwards flow on the other. Material therefore flowed from one hemisphere to the other", Meier reports. Surprisingly, the direction was not always the same. "Based on what we are used to from Earth, you would expect the material on the hot dayside to be lighter and therefore flow upwards and vice versa", co-author Dan Bower at the University of Bern and the NCCR PlanetS explains. Yet, some of the teams' simulations also showed the opposite flow direction. "This initially counter-intuitive result is due to the change in viscosity with temperature: cold material is stiffer and therefore doesn't want to bend, break or subduct into the interior. Warm material, however, is less viscous - so even solid rock becomes more mobile when heated - and can readily flow towards the planet's interior", Bower elaborates. Either way, these results show how a planetary surface and interior can exchange material under conditions very different from those on Earth.

A volcanic hemisphere

Such material flow could have bizarre consequences. "On whichever side of the planet the material flows upwards, one would expect a large amount of volcanism on that particular side", Bower points out. He continues "similar deep upwelling flows on Earth drive volcanic activity at Hawaii and Iceland". One could therefore imagine a hemisphere with countless volcanoes - a volcanic hemisphere so to speak - and one with almost none.

"Our simulations show how such patterns could manifest, but it would require more detailed observations to verify. For example, with a higher-resolution map of surface temperature that could point to enhanced outgassing from volcanism, or detection of volcanic gases. This is something we hope future research will help us to understand", Meier concludes.

Bernese space exploration: With the world's elite since the first moon landing

When the second man, "Buzz" Aldrin, stepped out of the lunar module on July 21, 1969, the first task he did was to set up the Bernese Solar Wind Composition experiment (SWC) also known as the "solar wind sail" by planting it in the ground of the moon, even before the American flag. This experiment, which was planned and the results analysed by Prof. Dr. Johannes Geiss and his team from the Physics Institute of the University of Bern, was the first great highlight in the history of Bernese space exploration.

Ever since Bernese space exploration has been among the world's elite. The numbers are impressive: 25 times were instruments flown into the upper atmosphere and ionosphere using rockets (1967-1993), 9 times into the stratosphere with balloon flights (1991-2008), over 30 instruments were flown on space probes, and with CHEOPS the University of Bern shares responsibility with ESA for a whole mission.

The successful work of the Department of Space Research and Planetary Sciences (WP)from the Physics Institute of the University of Bern was consolidated by the foundation of a university competence center, the Center for Space and Habitability (CSH). The Swiss National Fund also awarded the University of Bern the National Center of Competence in Research (NCCR) PlanetS, which it manages together with the University of Geneva.

Credit: 
University of Bern

Want to cut emissions that cause climate change? Tax carbon

COLUMBUS, Ohio - Putting a price on producing carbon is the cheapest, most efficient policy change legislators can make to reduce emissions that cause climate change, new research suggests.

The case study, published recently in the journal Current Sustainable/Renewable Energy Reports, analyzed the costs and effects that a variety of policy changes would have on reducing carbon dioxide emissions from electricity generation in Texas and found that adding a price, based on the cost of climate change, to carbon was the most effective.

"If the goal is reducing carbon dioxide in the atmosphere, what we found is that putting a price on carbon and then letting suppliers and consumers make their production and consumption choices accordingly is much more effective than other policies," said Ramteen Sioshansi, senior author of the study and an integrated systems engineering professor at The Ohio State University.

The study did not examine how policy changes might affect the reliability of the Texas power system - an issue that became acute and painful for Texas residents last month when a winter storm caused the state's power grid to go down.

But it did evaluate other policies, including mandates that a certain amount of energy in a region's energy portfolio come from renewable sources, and found that they were either more expensive or not as effective as carbon taxes at reducing the amount of carbon dioxide in the air. Subsidies for renewable energy sources were the also not as effective at reducing carbon dioxide, the study found.

The researchers modeled what might happen if the government used these various methods to cut carbon emission to be 80% below the 2010 level by the end of 2040.

They found that carbon taxes on coal and natural-gas-fired producing units could achieve those cuts at about half the cost of tax credits for renewable energy sources.

The study was led by Yixian Liu, a former graduate student in Sioshansi's lab, who is now a research scientist at Amazon. It modeled the expenses and carbon reductions possible from five generation technologies - wind, solar, nuclear, natural gas and coal-fired units - along with the costs and carbon reductions associated with storing energy. Storing energy is crucial, because it allows energy systems to manage renewable energy resources as sources shift from climate-change-causing fossil fuels - natural gas and coal - to cleaner sources like wind and solar.

Sioshansi said the results of the study were not surprising, given that a similar program has been in use to reduce levels of sulfur dioxide, one of the chemicals that causes acid rain.

"We have known for the last 40 or more years that market-based solutions can work on issues like this," Sioshansi said.

Although subsidies for renewable sources would work to decrease carbon emissions, the costs of those subsidies would be an issue, the study found.

"If no one had to pay for the subsidies and they were truly free, that would be a great option," Sioshansi said. "Unfortunately, that is not how they work."

Credit: 
Ohio State University

Researchers successfully determine annual changes in genetic ancestry within Finland

Commercially available gene tests that shed light on individual's origins are popular. They provide an estimate of the geographic regions where one's ancestors come from. To arrive at such an estimate, the genetic information of an individual is compared to information pertaining to reference groups collected from around the world.

The findings now made by researchers from the University of Helsinki, Aalto University and the Finnish Institute for Health and Welfare make it possible, for the first time, to make similar comparisons within Finland.

A research group at the University of Helsinki, headed by Associate Professor Matti Pirinen, who directed the study, has already earlier produced very detailed information on genetic structure in Finland. In the recently published study, reference groups were compiled from Finns with similar genetic ancestry and then applied to track the effects of migration in the 20th century on the population level.

The results have been published in the PLoS Genetics journal. In addition, the researchers have launched a website for the project, where anyone can browse the results using an interactive map.

The work is based on samples collected in the FINRISK study by the Finnish Institute for Health and Welfare. Using the reference datasets compiled from the samples, Finns can be classified on three different levels according to their geographical origin with fairly high precision. The first level separates Finns on the east-west axis, while the 10 different reference groups on the most detailed level partially match the former provinces of Finland.

The model used in the comparison works best when most of the individual's ancestors are from the same geographic region. The greater the dispersion of the ancestors, the less accurate the estimate provided by the model is.

"Determining genetic ancestry on nearly the provincial level in Finland would be exciting for anyone interested in recent history," says Sini Kerminen, who recently published a doctoral thesis on the topic at the University of Helsinki's Institute for Molecular Medicine Finland (FIMM).

Furthermore, the study observed the effect of recent genetic mixing in different areas in Finland on the basis of people's year and place of birth. A study of this temporal and geographical precision has never before been conducted anywhere in the world.

According to the findings, the genetic impact of the evacuation of the Karelian region ceded to the Soviet Union has been greater than that of the post-war urbanisation. Moreover, clear differences were seen within Finland with regard to how much population mixing had taken place in the period covered by the study, from the 1920s to the 1980s.

The most notable change was seen in the Uusimaa, Varsinais-Suomi and Häme regions, where the share of southwestern ancestry had declined by more than 20 percentage points. Changes of such magnitude and speed illustrate migration within the country and indicate that more people have migrated in the 20th century from east to west than in the opposite direction in Finland. The least change was observed in the Ostrobothnia region.

"By monitoring the share of the Karelian ancestry in the newborn population of the regions studied we can trace the movement of evacuees at almost an annual level. For example, Karelian ancestry in Ostrobothnia appears to have increased substantially in wartime. However, already in the 1950s it had largely disappeared from the region, unlike in the Uusimaa region and southwest Finland where the share of Karelian ancestry seems to have stabilised at the wartime level," says Associate Professor Pirinen.

According to the research group, detailed understanding of the fine-scale genetic structure of the population is also important for medical projects that utilise genomic information.

"Finally, we want to emphasise that genetic background is not the same as national or cultural identity, which means that our results cannot be used to determine who is a Finn," Pirinen states.

Credit: 
University of Helsinki

Thin explosive films provide snapshot of how detonations start

video: Videos of test detonations at Sandia National Laboratories of thin explosive films, about as thick as a few pieces of notebook paper.

Image: 
Sandia National Laboratories

ALBUQUERQUE, N.M. -- Using thin films -- no more than a few pieces of notebook paper thick -- of a common explosive chemical, researchers from Sandia National Laboratories studied how small-scale explosions start and grow. Sandia is the only lab in the U.S. that can make such detonatable thin films.

These experiments advanced fundamental knowledge of detonations. The data were also used to improve a Sandia-developed computer-modeling program used by universities, private companies and the Department of Defense to simulate how large-scale detonations initiate and propagate.

"It's neat, we're really pushing the limits on the scale at which you can detonate and what you can do with explosives in terms of changing various properties," said Eric Forrest, the lead researcher on the project. "Traditional explosives theory says that you shouldn't be able to detonate at these length scales, but we've been able to demonstrate that, in fact, you can."

Forrest and the rest of the research team, shared their work studying the characteristics of these thin films and the explosions they produce in two recently published papers in ACS Applied Materials and Interfaces and Propellants, Explosives, Pyrotechnics.

For their studies, the team used PETN, also known as pentaerythritol tetranitrate, which is a bit more powerful than TNT, pound for pound. It is commonly used by the mining industry and by the military.

Typically, PETN is pressed into cylinders or pellets for use. The research team instead used a method called physical vapor deposition -- also used to make second-generation solar panels and to coat some jewelry -- to "grow" thin films of PETN.

Sandia is the only lab in the U.S. that has the skills and equipment to use this technique to make thin explosive films that can detonate, said Rob Knepper, a Sandia explosives expert involved in the project.

Growing and studying thin explosive films

Starting in late 2015, the team grew thin films of PETN on different types of surfaces to determine how that would affect the films' characteristics. They started with pieces of silicon about the size of a pinkie nail and grew films that were about one-tenth the thickness of a piece of paper, too thin to explode. Some of the silicon pieces were very clean, some were moderately clean, and some were straight-out-of-the-box and thus had a very thin layer of dirt -- 50,000 times thinner than a sheet of paper.

On the very clean silicon surfaces, the PETN films formed what appeared to be smooth plates by scanning-electron microscopy, yet had tiny cracks in between plates, somewhat like dried mud on a dried lakebed. On the dirty silicon surfaces, the surface of the PETN films appeared more like even hills.

Using an X-ray-based technique, the researchers determined this is because the PETN molecules orient themselves differently on dirty surfaces compared to very clean surfaces, and thus the film grows differently, Forrest said.

"This study in particular has shown that we can get not just novel, but very useful forms of traditional explosives that you would never be able to achieve via traditional means," Forrest said. "Finely controlling the film properties enables us to investigate theories to better understand explosive initiation, which will allow us to better predict reliability, performance and safety of explosive systems through improved models."

Knepper, who served as Forrest's mentor on the project, agreed. "Developing a way that we can reproducibly control the microstructure of the films, just through the surface manipulation, is important. Right now, our focus is on using these films to further our understanding of explosive properties at small scales, such as the initiation and failure of explosives."

Small-scale tests to improve computer models

Once the characteristics and properties of the thin films were better understood, the research team grew thicker films -- this time about the thickness of two sheets of notebook paper -- on very clean pieces of plastic about the size of a pinkie finger.

Then, with a bang, they detonated the explosive films inside a specially designed safety enclosure called a "boombox," which was engineered to prevent a detonation from starting while the enclosure was open and contain any debris from the detonation. Using an ultra-high-speed camera that can take up to a billion frames a second, they watched the shock wave rise up as the explosion raced across the thin film.

In collaboration with New Mexico Institute of Mining and Technology in Socorro, the research team developed a specialized setup to see the shock wave despite the smoke and debris from the test explosions using schlieren imaging, a technique that can detect differences in air density similar to the shimmering over a hot highway.

A mechanical engineering master's student from New Mexico Tech, Julio Peguero, used the data from these experiments to refine Sandia's explosives computer-modeling program. The program, called CTH, can be used for applications, such as to determine how to best shape explosive charges while drilling for oil, Knepper said.

Peguero plotted the velocity of the shock waves above the films with and without gaps and adapted the computer program to better match their experimental results on very thin films. The team engineered thin films with cracks in the middle of various sizes -- ranging from one-third the width of a human hair to 1 1/3 the width of a hair -- to better understand the reliability of thin films and how detonations can fail. The team found that gaps around the size of a hair could stop a detonation from continuing.

Forrest was particularly interested in the gap studies because the first study found thin cracks between the very smooth plates of some of the films. Although these cracks were far smaller than even one-tenth a hair's width, the data from the gap study provided insights into how these films would perform.

Peguero, who is now a Sandia employee started working on the project in January 2018, first as a student and then later as a Sandia intern. "In addition to the excitement of doing explosives research, I gained an appreciation for measurement uncertainty and risks," Peguero said. "That is especially important for national security work to ensure that our confidence in our measurements is well-understood."

Knepper agreed about the importance of the project. He said, "When you have experimental data at small scales, especially those that are relevant for the border between what can detonate and what can't, those data can be really helpful in calibrating computer models. Also, being able to have good characterization of the explosive microstructure to go into the models helps with having parameters that can successfully predict performance over a wider range of explosive behaviors."

Credit: 
DOE/Sandia National Laboratories

NASA's ICESat-2 satellite reveals shape, depth of Antarctic ice shelf fractures

image: Satellite imagery of the Amery Ice Shelf in East Antarctica. The blue lines represent the movement of the ice as it flows from the continent to the edge of the ice shelf, where it calves, or breaks off into the ocean. Satellite data can now help researchers determine where these calving events will occur.

Image: 
Shujie Wang, Penn State

When a block of ice the size of Houston, Texas, broke off from East Antarctica's Amery Ice Shelf in 2019, scientists had anticipated the calving event, but not exactly where it would happen. Now, satellite data can help scientists measure the depth and shape of ice shelf fractures to better predict when and where calving events will occur, according to researchers.

Ice shelves make up nearly 75% of Antarctica's coastline and buttress -- or hold back -- the larger glaciers on land, said Shujie Wang, assistant professor of geography at Penn State. If the ice shelves were to collapse and Antarctica's glaciers fell or melted into the ocean, sea levels would rise by up to 200 feet.

"When we try to predict the future contribution of Antarctica to sea-level rise, the biggest uncertainty is ice shelf stability," said Wang, who also holds an appointment in the Earth and Environmental Systems Institute. "There's no easy way to map the depth of fractures in the field over a regional scale. We found that satellite data can capture the depth and surface morphology of ice shelf fractures and thereby allow us to consistently monitor this information over a large range."

Wang and her colleagues examined high-resolution data collected by the Ice, Cloud and Land Elevation Satellite (ICESat-2) over the Amery Ice Shelf, which is about the size of West Virginia, between October 2018 and November 2019. The satellite shoots green laser pulses to the land surface and uses reflected photons to determine surface height. Whereas other satellites have a resolution of several thousands of feet, ICESat-2 has a resolution of approximately 56 feet, enabling it to see smaller fractures and the fracture morphology.

The researchers then ran the ICESat-2 data through an algorithm that identifies surface depression features to locate and characterize fractures in the ice. They reported their results in the journal Remote Sensing of Environment.

The researchers identified three types of fractures -- U-shaped, parabolic-shaped and V-shaped fractures -- up to 164 feet deep in the ice shelf. They also realized that this surface information provides insights into what is happening hundreds of feet below the surface of the ice.

Basal fracture morphology -- the shape and size of fractures at the base of the ice shelf -- is proportional to the surface depressions, according to Wang. As the glacier that the ice sheet is buttressing accumulates more snow and ice, the parabolic-shaped fractures flow toward the edges of the ice shelf. Once they cross a certain boundary, those surface fractures have a greater potential to penetrate deeper into the ice as the basal fractures extend upward. These fractures can then become V-shaped, potentially signaling that a rift -- a fracture that penetrates the entire thickness of the ice sheet -- has formed. These rifts are more likely to cause calving events.

"Incorporating satellite-based vertical information can improve future ice shelf models," Wang said. "It can help us actually predict calving fronts and where an ice shelf is vulnerable to these events."

Credit: 
Penn State

Rapid new automated genomics screening stamps out crop disease

Researchers at the Earlham Institute (EI) have created a new automated workflow using liquid handling robots to identify the genetic basis to prevent plant pathogens, which can be used on a much larger and rapid scale than current methods.

The new EI Biofoundry automated workflow gives scientists an enhanced visual check of genetic mutations linked to the control of crop disease, speeding up analysis to a fraction of the time compared to current methods - from months to weeks - accelerating development of novel products for crop protection in the agricultural industry.

Biosynthesis is the formation of chemical compounds by a living organism, or a biosynthetic process modeled on these reactions in living organisms.

The EI biofoundry, alongside the Truman Group at the John Innes Centre, used this workflow to experiment on the control of the common potato pathogen, Streptomyces scabies, which causes a devastating disease known as 'potato scab', by Pseudomonas sp. (bacteria).

The team screened 2,880 Pseudomonas sp. (isolated from potato field) mutants with the plant pathogen in just 11 hours, to identify and correlate the pathogen growth inhibition with a biosynthetic gene cluster within two weeks - indicating which genes were preventing the pathogen.

This approach will pinpoint genes involved in pathogen growth inhibition by bacteria, not the plant themselves; where either a bacterial strain or a molecule produced by a bacterial strain, would end up as the crop protection product.

The new EI automated workflow will allow scientists to scale-up the process of identifying Pseudomonas gene clusters that are responsible for restricting pathogen growth, avoiding human error, and increasing reproducibility and accuracy. The engineering biology workflow can also be applied to similar bacterial genome analyses.

Biofoundries integrate high-throughput software and hardware platforms with synthetic biology approaches to enable the design, execution and analyses of large-scale experiments. The unique and powerful combination of EI's Biofoundry infrastructure, expertise in molecular biology, and automation programming provide flexible resources for a wide range of workflows and research areas.

Co-Corresponding author of the study and Earlham BIO Foundry Manager Dr Jose A. Carrasco Lopez, said: "We demonstrate the applicability of biofoundries to molecular microbiology by using automated workflows to identify the genetic basis of growth inhibition of the plant pathogen Streptomyces scabies by a Pseudomonas strain isolated from a potato field.

"The EI Biofoundry generated workflow resulted in the identification of a gene cluster linked to the inhibitory effect on the potato pathogen which made the process much easier. By identifying the new genetic determinants, it opens the door to finding the metabolites involved in pathogen inhibition."

The new workflow will help scientists to understand how the genes are involved in the synthesis of the inhibitory metabolites, look at the species' inhibitory range and how these genes can be used for biocontrol, and how Pseudomonas is resistant to the very same inhibitory metabolite it's producing.

"Manual screenings are usually performed with pin replicators in the same plate, where many mutants are together in the presence of the pathogen," adds Dr Carrasco Lopez. "This means that a mutant in a non-related gene could mask the lack of inhibitory effect of a real-hit mutant by proximity."

"We solved this by creating individual assays for each mutant - this impacts the scientific community significantly, and provides enhanced control of crop pathogens based on biological processes which will translate into better crop yields."

Although these microbiological methods have been used before, with screening of well-known mutant libraries, this innovative study has for the first time used an automated screening process to reduce the required time and complete the process in weeks; whereas manually, it could take months.

Collaborator and first author Alaster Moffat, PhD student in the Truman Lab, who approached EI about the possibility of automating the biosynthetic screening, said: "We had previously been unable to identify genes important for inhibiting the growth of the pathogen using bioinformatics approaches, but this workflow allowed us to rapidly probe the effects of almost every accessory gene in the Pseudomonas isolate's genome directly, and find a novel biosynthetic gene cluster within a very short timeframe."

The EI Biofoundry plans to progress the study by creating workflow modifications to adapt to new projects and pathogens. "Once we have identified the gene cluster involved in the synthesis of this new metabolite," says Dr Carrasco Lopez, "scientists could mutate every single gene to identify functions and essential genes for metabolite synthesis. This can be applied to control plant pathogens and further improve the potato crop's yield, to test the species' inhibitory range of these metabolites and to identify new genes from other bacterial species linked to the impairment of other crop pathogens."

Credit: 
Earlham Institute

New study examines importance and unique characteristics of US female farmers

UNIVERSITY PARK, Pa. -- While women can be drawn into farming for many reasons, researchers in Penn State's College of Agricultural Sciences have found that female-owned farms in the U.S. are more common in areas that are closer to urban markets, that engage in agritourism activity, and that offer greater access to childcare.

The number of farms operated by women has risen over the past two decades, said Claudia Schmidt, assistant professor of marketing and local/regional food systems.

The U.S. Department of Agriculture changed the way it counts the operators of farms in its most recent Census of Agriculture, allowing for up to four principal operators per farm. This has inflated the number of female operators somewhat, but female participation in agriculture is nonetheless at an all-time high, said Schmidt.

"This type of research is needed not just for reasons of equity, but also to support a more diverse and resilient agricultural sector in general," said Schmidt. "Without knowing more about female farm-operators' decision making, agricultural service providers have had to make assumptions about the type of information and products that are useful to them. Our analysis shows some of the ways in which female-owned farms are unique and it can offer important insights into how best to serve this population."

Using data from the U.S. Census of Agriculture from 2002-2017, Schmidt and her colleagues developed a statistical model to examine the relationship between a county's share of female-operated farms and the conditions in the county. Their goal was to shed light on aspects of the local economic and agricultural ecosystems that are most strongly associated with female-owned farms.

The researchers identified 10 economic variables hypothesized to matter, including unemployment, non-farm wages, availability of childcare, and the rate of female participation in the labor force. They also examined the total number of farms, average farm size and annual sales, average farmer age, and the types of farm activities carried out. They looked at each variable in isolation to determine which variables are independently and most strongly associated with the share of female-operated farms.

"We wanted to understand why women are drawn to farming," said Stephan Goetz, professor of agricultural and regional economics and director of the Northeast Regional Center for Rural Development (NERCRD). "Is it because they want to engage in this kind of work, or is it because they are pushed into farming due to a lack of other economic opportunities locally? We also wanted to examine how local agricultural conditions -- what farming generally looks like in a given place -- relate to women's participation in agriculture."

The analysis, which was recently published in Food Policy, shows that more female-owned farms are found where average farm size is below 50 acres, where annual farm sales average less than $10,000 per farm, where more farms specialize in grazing sheep or goats, and where agritourism activities -- which attract visitors to farms -- are more common.

The researchers also found that direct-to-consumer sales are more prevalent in counties with more female-owned farms. It is therefore not surprising that urban areas with high population densities have more female-owned farms than more rural areas do, said Goetz.

"Our findings suggest that females are more likely to engage in the type of farming that benefits from being in or near urban locations," said Goetz. "In addition to offering more opportunities to market directly to consumers, urban and suburban locations also offer greater access to childcare than rural areas, and our research showed the availability of childcare is correlated with the number of female-owned farms in a county."

The researchers also noted that the share of farms with female operators is higher in counties with a greater total number of farms, which could reflect increased opportunities for networking and learning through knowledge-sharing networks.

"Our research suggests that female-owned farms are more common in certain economic and agricultural ecosystems," Schmidt said. "Therefore, they likely have different needs in terms of education and support, and this research is an important step in identifying these differences."

Among other questions, future research will look at the impact of female-owned farms on local economic and agricultural conditions.

Credit: 
Penn State

COVID-19 in 2021

What The Article Says: Current best evidence about COVID-19 vaccines, immunity and whether SARS-CoV-2 will become an endemic or seasonal virus is summarized in this Viewpoint.

Authors: Carlos del Rio, M.D., of the Emory University School of Medicine in Atlanta, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.3760)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

New evidence COVID-19 antibodies, vaccines less effective against variants

image: Physician assistant Philana Liang prepares a vial of COVID-19 vaccine on the Washington University Medical Campus. New research from Washington University School of Medicine in St. Louis has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs now being used to prevent or treat COVID-19.

Image: 
Matt Miller/Washington University

New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants.

The findings, from laboratory-based experiments and published March 4 in Nature Medicine, suggest that COVID-19 drugs and vaccines developed thus far may become less effective as the new variants become dominant, as experts say they inevitably will. The researchers looked at variants from South Africa, the United Kingdom and Brazil.

"We're concerned that people whom we'd expect to have a protective level of antibodies because they have had COVID-19 or been vaccinated against it, might not be protected against the new variants," said senior author Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine. "There's wide variation in how much antibody a person produces in response to vaccination or natural infection. Some people produce very high levels, and they would still likely be protected against the new, worrisome variants. But some people, especially older and immunocompromised people, may not make such high levels of antibodies. If the level of antibody needed for protection goes up tenfold, as our data indicate it does, they may not have enough. The concern is that the people who need protection the most are the ones least likely to have it."

The virus that causes COVID-19, known as SARS-CoV-2, uses a protein called spike to latch onto and get inside cells. People infected with SARS-CoV-2 generate the most protective antibodies against the spike protein.

Consequently, spike became the prime target for COVID-19 drug and vaccine developers. The three vaccines authorized by the Food and Drug Administration (FDA) for emergency use in the U.S. -- made by Pfizer/BioNTech, Moderna and Johnson & Johnson -- both target spike. And potent anti-spike antibodies were selected for development into antibody-based drugs for COVID-19.

Viruses are always mutating, but for nearly a year the mutations that arose in SARS-CoV-2 did not threaten this spike-based strategy. Then, this winter, fast-spreading variants were detected in the United Kingdom, South Africa, Brazil and elsewhere. Sparking concern, the new variants all carry multiple mutations in their spike genes, which could lessen the effectiveness of spike-targeted drugs and vaccines now being used to prevent or treat COVID-19. The most worrisome new variants were given the names of B.1.1.7 (from the U.K.), B.1.135 (South Africa) and B.1.1.248, also known as P.1 (Brazil).

To assess whether the new variants could evade antibodies made for the original form of the virus, Diamond and colleagues, including first author Rita E. Chen, a graduate student in Diamond's lab, tested the ability of antibodies to neutralize three virus variants in the laboratory.

The researchers tested the variants against antibodies in the blood of people who had recovered from SARS-CoV-2 infection or were vaccinated with the Pfizer vaccine. They also tested antibodies in the blood of mice, hamsters and monkeys that had been vaccinated with an experimental COVID-19 vaccine, developed at Washington University School of Medicine, that can be given through the nose. The B.1.1.7 (U.K.) variant could be neutralized with similar levels of antibodies as were needed to neutralize the original virus. But the other two variants required from 3.5 to 10 times as much antibody for neutralization.

Then, they tested monoclonal antibodies: mass-produced replicas of individual antibodies that are exceptionally good at neutralizing the original virus. When the researchers tested the new viral variants against a panel of monoclonal antibodies, the results ranged from broadly effective to completely ineffective.

Since each virus variant carried multiple mutations in the spike gene, the researchers created a panel of viruses with single mutations so they could parse out the effect of each mutation. Most of the variation in antibody effectiveness could be attributed to a single amino acid change in the spike protein. This change, called E484K, was found in the B.1.135 (South Africa) and B.1.1.248 (Brazil) variants, but not B.1.1.7 (U.K.). The B.1.135 variant is widespread in South Africa, which may explain why one of the vaccines tested in people was less effective in South Africa than in the U.S., where the variant is still rare, Diamond said.

"We don't exactly know what the consequences of these new variants are going to be yet," said Diamond, also a professor of molecular microbiology and of pathology & immunology. "Antibodies are not the only measure of protection; other elements of the immune system may be able to compensate for increased resistance to antibodies. That's going to be determined over time, epidemiologically, as we see what happens as these variants spread. Will we see reinfections? Will we see vaccines lose efficacy and drug resistance emerge? I hope not. But it's clear that we will need to continually screen antibodies to make sure they're still working as new variants arise and spread and potentially adjust our vaccine and antibody-treatment strategies."

Credit: 
Washington University School of Medicine

Smoking cessation drug may treat Parkinson's in women

Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.

Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the Journal of Neurochemistry.

There are approximately 10 million people worldwide living with Parkinson's disease, a neurodegenerative disorder that leads to a variety of symptoms that can include difficulty walking, tremors, shaking and others unrelated to movement. These symptoms start to develop when at least 50 percent of dopamine neurons in an individual's brain are dead or impaired. Currently, there is no cure for Parkinson's and no treatment that can stop or prevent the loss of these dopamine neurons that are needed for the body to move.

About a decade ago, Srinivasan became interested in trying to understand why smokers and people who consume tobacco chronically are at a lower risk for developing Parkinson's disease.

"Based on epidemiological studies, this phenomenon has been known for about 60 years," Srinivasan said. "But people really don't understand why that is, because tobacco and smoke contain so many different chemicals. One of the chemicals obviously is nicotine, and that explains the addictive properties of tobacco and cigarette smoke. So, I started to study the potential role of nicotine in this protective effect against Parkinson's disease."

Given the fact that it is very difficult to conduct human and animal trials using nicotine due to severe side-effects, Srinivasan decided to test cytisine as an alternative to nicotine. Cytisine is a smoking cessation drug with properties similar to nicotine, but with very few side effects in people.

"What cytisine does is it binds to target receptors but doesn't activate them as efficiently as nicotine," Srinivasan said. "It keeps the receptors 'occupied' and 'chaperones' them to the surface of the neuron. Since cytisine is a natural compound, is available quite freely and is pretty cheap, I decided to test this concept of chaperoning in an animal model of the disease to see if it works."

During experiments, the team artificially induced Parkinson's disease in animal models. During that time, they either gave them saline (salt water) or cytisine. Then, the researchers performed a series of behavioral experiments in order to see if there was any sort of protective effect on the animal models that were given cytisine.

Their findings showed that there was a protective effect both in terms of reducing the Parkinsonian behaviors and also in terms of reducing the number of dopamine neurons lost. However, the protective effect of cytisine occurred only in female animal models, and not in the males. They discovered that the combination of cytisine and estrogen produces a stronger protective effect than cytisine and no estrogen. This explains why the effect only occurred in female animal models, since males do not have appreciable amounts of estrogen.

Although their findings currently only apply to females, Srinivasan hopes to find solutions for males and postmenopausal females, too.

"What is really interesting is that there are non-feminizing compounds that have been developed and are being researched right now that can activate the receptors that estrogen activates," Srinivasan said. "The goal right now is to understand how estrogen triggers the protection in female animal models. Once we fully understand this component, then we can bring in these non-feminizing estrogen analogs, and we will potentially have a combination therapy of cytisine and a non-feminizing estrogen analog for men."

The next step for Srinivasan and his team is to solidify and confirm the role of estrogen specifically as a protective effect against Parkinson's disease.

"At the face of it, this drug is ready to be used today in women with Parkinson's, but as is true for all drugs, you cannot get approval for a drug until you understand what the mechanism of the actual drug is exactly, which is our next step," Srinivasan said. "This first paper is the description of a protective effect and a potential mechanism for cytisine against Parkinson's disease. The next steps are to nail down the mechanisms by which this is happening, the role of estrogen specifically. Once we do that, we will use cytisine for women before menopause or cytisine combined with non-feminizing estrogen analogs for both men and women, including women after menopause."

Credit: 
Texas A&M University

Key enzymes for synthesizing natural products

Plants, fungi, and bacteria produce natural products that function, among other things, as defenses that are deployed against predators and competitors. In medicine, these compounds are used for antibiotics, cancer drugs, and cholesterol reducers. The team working with associate professor Dr. Robin Teufel and Dr. Britta Frensch of the Institute of Biology II of the Faculty of Biology of the University of Freiburg was able, together with researchers from the ETH Zürich in Switzerland, to shed light on the key role of three enzymes that are involved in synthesizing a class of natural products. The researchers are publishing their findings in the latest edition of "Nature Communications."

Actinobacteria produce many natural products, such as those that are known as aromatic polyketides. The Freiburg researchers examined how actinobacteria - aided by enzymes - were able to synthesize such bioactive substances from simple, molecular components. Teufel and his team were able to illuminate the key roles played by three enzymes in the biosynthesis of rubromycins, which belong to the most structurally complex aromatic polyketides.

The researchers discovered that the enzymes drastically restructure a chemical precursor molecule. Through this process they create the carbon backbone of the rubromycins, which is key to the diverse, pharmacological effects of these compounds. Using chemical and biochemical methods, the researchers succeeded in examining the functions of the enzymes more closely and identifying several previously unknown intermediates in the biosynthesis of the rubromycins. Teufel explains, "We've made important findings about the ways such enzymes control the formation of complex natural products in microorganisms. These findings could play a central role in applying bioengineering to make new types of bioactive rubromycin-polyketides."

Credit: 
University of Freiburg

Will climate change outpace species adaptation?

Many species might be left vulnerable in the face of climate change, unable to adapt their physiologies to respond to rapid global warming. According to a team of international researchers, species evolve heat tolerance more slowly than cold tolerance, and the level of heat they can adapt to has limits.

In a study published in the Nature Communications, McGill professor Jennifer Sunday and her co-authors wanted to understand how species' thermal limits have evolved. To examine variation across the tree of life, the researchers developed the largest available database compiling thermal tolerances for all types of organisms (GlobTherm database).

The researchers found that first and foremost, a species' thermal tolerance is linked to the current climate where they live. "It's logical that thermal limits mostly match a species' present-day climate but tracing the evolutionary history of thermal limits can reveal how species got to be where they are today," says Sunday, an Assistant Professor in the Department of Biology.

The researchers also found that tolerance to cold has evolved much faster than tolerance to heat, particularly in endotherms as compared to ectotherms and plants. Endothermic animals are those that generate metabolic heat to regulate their own body temperature - for example, mammals and birds - while ectothermic animals are those that regulate their body temperature using external heat sources, like reptiles, fishes and invertebrates.

One cause of this disparity could be that heat tolerance has reached an evolutionary barrier, called an 'attractor,' beyond which further evolution is constrained or selected against. "This is very concerning because it suggests that the vast majority of species will not be able to adapt fast enough to survive the unprecedented rate of contemporary climate change," says co-author Joanne Bennett of Leipzig University and University of Canberra.

The results of this study are particularly relevant to conservation management, say the researchers. Protecting and creating areas that provide refuges for biodiversity from upper temperature extremes is a key strategy for conservation managers.

Credit: 
McGill University

COVID-19 nasal swab test may not be best for those who've had sinus surgery

SAN ANTONIO, March 4, 2021 -- People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates.

Likewise, those performing swab testing should ask whether the patient has had extensive sinus or skull base surgery, said Philip G. Chen, MD, study senior author from The University of Texas Health Science Center at San Antonio (UT Health San Antonio).

"If so, other modes of testing such as at the back of the throat should be performed," said Dr. Chen, associate professor of otolaryngology-head and neck surgery in the university's Joe R. and Teresa Lozano Long School of Medicine.

JAMA Otolaryngology-Head & Neck Surgery published the study March 4.

Online information about COVID nasopharyngeal swabs lacks information warning those with prior extensive sinus or skull base surgery, Dr. Chen said.

"Not one site of the 200 we searched online had information cautioning against blind nasopharyngeal swab testing in those with a history of sinus or skull base surgery," he said.

Asked how often swabbing is done incorrectly, Dr. Chen said, "We really don't know that. But in a review of videos online by Higgins, et al., the authors found that about half of the videos on how to perform COVID-19 nasopharyngeal swabs were incorrect."

Issues include incorrect angling of the swab and inappropriate depth of insertion. If the swab angle is too high, a puncture may occur. The sinuses can protect the skull base to a degree, Dr. Chen said.

Injury from incorrect nasopharyngeal swab technique, while rare, may include cerebrospinal fluid leakage or severe bleeding.

Polymerase chain reaction via nasopharyngeal swabs is a test frequently used to detect SARS-CoV-2 infection.

Dr. Chen is a board-certified, fellowship-trained rhinologist -- the only fellowship-trained physician of this rare specialization in San Antonio. Rhinologists are ear, nose and throat (ENT) subspecialists who have unique interest and expertise in medical and surgical treatment of nasal and sinus disorders.

Credit: 
University of Texas Health Science Center at San Antonio

Demand for public health graduates remains high through the COVID-19 pandemic

March 4, 2021 -- COVID?19 has altered the labor market for millions of people, including public health graduates, yet an analysis of job postings for Master's level public health graduates showed that job postings remained at the same levels as before the pandemic, according to a new study at Columbia University Mailman School of Public Health. The findings are published in the International Journal of Health Planning and Management.

"Due to the crucial role of disease prevention in responding to and recovering from the COVID?19 pandemic, assessing the public health workforce remains critically important," said Heather Krasna, MS, EdM, assistant dean of career services at Columbia Mailman School, and lead author of the study. "Fortunately, the job market for master's level public health graduates has not been as negatively impacted by the COVID?19 pandemic as compared with the broader job market." Alternatively, overall job postings nationally dropped by up to 30 percent in the U. S. due to the pandemic.

An analysis of more than 38,533 job postings for master's level public health grads found that there were 92 different occupations which sought to hire public health graduates or that existed within the public health workforce.

To pinpoint changing employer demands associated with COVID?19, the researchers analyzed 24,516 postings from March 2019 to October 2019 - pre-COVID -- and compared them with 24,845 postings from March 2020 to October 2020 in the COVID era. The study utilized a job postings database, maintained by Burning Glass (BG) Technologies.

"Through an analysis of job postings in two timeframes, before COVID?19 and during the COVID?19 pandemic, we can assess whether demand for public health graduates has changed during the COVID?19 pandemic," said Krasna. "While there is no doubt that the labor market for millions of people changed with COVID-19, including public health graduates, it is notable that there were several hundred more job postings for public health graduates in the COVID-era, compared to pre-COVID jobs."

Pharmaceutical companies and insurance firms increased their numbers of job postings for public health graduates, while nonprofits and academia have seen job postings drop during COVID-19. Since the pandemic, up to 28 percent of job postings for public health graduates were in fields outside of the job definitions which have traditionally been listed as part of the public health workforce.

According to Krasna and colleagues, with this latest analysis, workforce planners and academic institutions can help identify possible workforce gaps, ensure that curriculum addresses the current needs of organizations hiring public health graduates, and provide insights to academia for curricula innovation.

The data also show a shortfall of positions for approximately 19 percent of Master's level public health graduates entering into government after graduation. This mismatch--in which not enough public health graduates are entering government to fill critical public health workforce shortages--may have serious repercussions for the ability of the governmental public health agencies to respond to public health crises including COVID?19.

The jobs with the fastest increases in hiring during the COVID?19 era focus on statistics and epidemiology, program management, computer?related positions, community health workers, and individuals managing clinical trials or research programs. An increased need for Chief Executives highlights the need for leadership training to meet the COVID?19 pandemic's management challenges or replace retiring public health executives. Universities preparing public health graduates can utilize this analysis to discern real?time job market requirements of employers, noted Krasna.

Credit: 
Columbia University's Mailman School of Public Health